From ESS to the JDS: Dr Murray Johns’ drowsiness detection technology enters the pharmaceutical industry

Optalert revolutionises pharmaceutical research with in-clinic test for wakefulness. Richmond, VIC: Optalert is pleased to introduce its latest wakefulness detection technology to the pharmaceutical industry for use during clinical drug trials. Optalert’s technology enhances clinical testing by offering pharmaceutical researchers an objective, measurable and real-time scale of drowsiness in addition to the alternative wakefulness, common...

Search

Categories

Categories

Date

Date

Search

Categories

Categories

Date

Date